Apixaban intermediates / CAS  27143-07-3

Apixaban intermediates / CAS 27143-07-3


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
China
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
1575-61-7, 27143-07-3, 503615-07-4, 545445-44-1
Category
Pharmaceutical Intermediates

Nanjing CHICO pharmaceutical Co.,Ltd.

Membership
PRO
Country / Year Established
China China / 2008
Business type
Manufacturer
Verified Certificate

10

Product name Apixaban intermediates / CAS 27143-07-3 Certification -
Category Pharmaceutical Intermediates Ingredients -
Keyword 1575-61-7 , 27143-07-3 , 503615-07-4 , 545445-44-1 Unit Size -
Brand name - Unit Weigh -
origin China Stock -
Supply type - HS code -

Product Information

 

Product Name:Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate

CAS No.:27143-07-3

Appearance: Pale yellow solid

Assay:≥98%

 

 Apixaban Intermediates

CAS No.:

Product Name

1575-61-7

5-Chlorovaleryl chloride

27143-07-3

Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate

536759-91-8

4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester

503615-07-4

ethyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate

545445-44-1

5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone

503612-47-3

Apixaban

 

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Nanjing CHICO pharmaceutical Co.,Ltd.

Country / Year Established
China China / 2008
Membership
PRO
Business type
Manufacturer

10

President
David Wu
Address
No.9 Weidi Road-Jiangsu life science and technology Innovation Park,Nanjing,China
Product Category
Organic Intermediate,Other Pharmaceutical Chemicals
Year Established
2008
No. of Total Employees
1-50
Company introduction

 

Established in 2008, Nanjing CHICO pharmaceutical Co.,Ltd. serving global pharmaceutical industry with best quality products and professional services. We offer APIs and intermediates with effective technical support and professional documentation service.

We have our teams that leaded by lots of pharmaceutical and chemical experts and professors which closely following the international new drug research and development dynamic that help us to provide a strong continuous innovation, and make us always stand in the forefront of new drug research and development.

Gradually we form a targeted anti-tumor, anticoagulant, anti-diabetes medicine raw materials and intermediate products system.

We have complete production chain of gram-kilogram-ton so that we can achieve rapid response in the whole R&D-scale up- producing process for new product and transform the technology into productivity at the first time.
We always regard the quality as life, so we establish a sound quality assurance system and strict quality control standards according to GMP requirements.

We are adhering to the "Consummate service Convincing honor" business strategy and  providing best quality products, competitive price ,professional service, and strict working style to meet our customer's need, reduce its product cost by strong technical accumulation and outstanding professionalism to face our customer's market challenges. We take our customers' success as our own success.

 

Main Markets

Germany Germany

India India

Iran Iran

Italy Italy

South Korea South Korea

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more